Back | Next |
home / stock / aktx / aktx message board
Subject | By | Source | When |
---|---|---|---|
Completely doomed company. Nobody touching it! More vol | candeloro | investorshub | 08/31/2020 6:27:40 PM |
Funny to read the messages from 2 years | candeloro | investorshub | 08/27/2020 8:05:44 PM |
yeah, pretty awful. | candeloro | investorshub | 08/27/2020 7:55:05 PM |
Akari Therapeutics P ($AKTX) | mick | investorshub | 08/27/2020 7:50:52 PM |
mick, old pump and dumper. Now 10% lower. | candeloro | investorshub | 08/27/2020 7:46:38 PM |
$AKTX Akari Therapeutics P ($AKTX) | mick | investorshub | 08/08/2020 9:45:33 PM |
$AKTX$ BIG TIME MOVE | mick | investorshub | 08/08/2020 9:45:17 PM |
Added a bunch Friday $AKTX. Have bigly position | Rogerthat1 | investorshub | 08/08/2020 9:24:12 PM |
$AKTX Akari Therapeutics PLC (NASDAQ: $AKTX): interim update | mick | investorshub | 08/05/2020 2:39:45 PM |
$AKTX going to be huge runner my friend !!!!! | mick | investorshub | 07/30/2020 1:40:55 AM |
$AKTX i am looking fer $8 plus !!!!! | mick | investorshub | 07/30/2020 1:38:27 AM |
$AKTX why not this wk ????? biotech are | mick | investorshub | 07/30/2020 1:36:54 AM |
$AKTX Akari Therapeutics P ($AKTX) | mick | investorshub | 07/30/2020 1:33:53 AM |
$AKTX I AGREE WITH PPS , EXCELLENT | mick | investorshub | 07/30/2020 1:33:37 AM |
Agreed. And I'm watching $AKTX for signs to | Ablivious | investorshub | 07/29/2020 1:55:10 PM |
Excellent to see some new posters here. Give | BrazenBull | investorshub | 07/29/2020 5:09:01 AM |
$AKTX here you have Akaris medical director as | Rogerthat1 | investorshub | 07/28/2020 4:37:10 AM |
I was buying $capr at 90 and been | Rogerthat1 | investorshub | 07/28/2020 2:01:12 AM |
$AKTX YOU ARE WELCOME. $AKTX Bid: 2.08 Ask: | mick | investorshub | 07/27/2020 9:05:00 PM |
Thanks for the post Mick. We are gold | MotionOffense78 | investorshub | 07/27/2020 8:55:30 PM |
News, Short Squeeze, Breakout and More Instantly...
Akari Therapeutics Plc Company Name:
AKTX Stock Symbol:
NASDAQ Market:
Entered into a Definitive Merger Agreement with Peak Bio; Expected to Close in the Third Quarter of 2024 Samir R. Patel, M.D. Appointed Interim CEO Plan for Prioritization of Peak Bio’s ADC Cancer Therapeutic Platform Technology and Akari’s PAS-nomacopan fo...
PRA Group Inc. (PRAA) is expected to report $-0.15 for Q1 2024 Bowman Consulting Group Ltd. (BWMN) is expected to report $-0.04 for Q1 2024 Noble Corporation plc A (NE) is expected to report $0.56 for Q1 2024 Velo3D Inc. (VLD) is expected to report for Q3 2024 Axon Enterprise Inc....
BOSTON and LONDON, May 01, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (NASDAQ:AKTX), a biotechnology company developing advanced therapies...